196 related articles for article (PubMed ID: 33515753)
1. LRRC8A contributes to angiotensin II-induced cardiac hypertrophy by interacting with NADPH oxidases via the C-terminal leucine-rich repeat domain.
Huo C; Liu Y; Li X; Xu R; Jia X; Hou L; Wang X
Free Radic Biol Med; 2021 Mar; 165():191-202. PubMed ID: 33515753
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiotensin II-induced cerebrovascular smooth muscle cell proliferation by LRRC8A downregulation through suppressing PI3K/AKT activation.
Lu J; Xu F; Zhang J
Hum Cell; 2019 Jul; 32(3):316-325. PubMed ID: 31127489
[TBL] [Abstract][Full Text] [Related]
3. Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.
Gang C; Qiang C; Xiangli C; Shifen P; Chong S; Lihong L
J Pharm Pharm Sci; 2015; 18(2):235-48. PubMed ID: 26158288
[TBL] [Abstract][Full Text] [Related]
4. LRRC8A channels support TNFα-induced superoxide production by Nox1 which is required for receptor endocytosis.
Choi H; Ettinger N; Rohrbough J; Dikalova A; Nguyen HN; Lamb FS
Free Radic Biol Med; 2016 Dec; 101():413-423. PubMed ID: 27838438
[TBL] [Abstract][Full Text] [Related]
5. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation.
Kawahara T; Ritsick D; Cheng G; Lambeth JD
J Biol Chem; 2005 Sep; 280(36):31859-69. PubMed ID: 15994299
[TBL] [Abstract][Full Text] [Related]
6. Stachydrine Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Suppressing Autophagy.
Cao TT; Chen HH; Dong Z; Xu YW; Zhao P; Guo W; Wei HC; Zhang C; Lu R
Cell Physiol Biochem; 2017; 42(1):103-114. PubMed ID: 28494450
[TBL] [Abstract][Full Text] [Related]
7. Oxidant-resistant LRRC8A/C anion channels support superoxide production by NADPH oxidase 1.
Choi H; Rohrbough JC; Nguyen HN; Dikalova A; Lamb FS
J Physiol; 2021 Jun; 599(12):3013-3036. PubMed ID: 33932953
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich repeat containing 8A (LRRC8A)-dependent volume-regulated anion channel activity is dispensable for T-cell development and function.
Platt CD; Chou J; Houlihan P; Badran YR; Kumar L; Bainter W; Poliani PL; Perez CJ; Dent SYR; Clapham DE; Benavides F; Geha RS
J Allergy Clin Immunol; 2017 Dec; 140(6):1651-1659.e1. PubMed ID: 28192143
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy.
Nakagami H; Takemoto M; Liao JK
J Mol Cell Cardiol; 2003 Jul; 35(7):851-9. PubMed ID: 12818576
[TBL] [Abstract][Full Text] [Related]
10. ClC-3 promotes angiotensin II-induced reactive oxygen species production in endothelial cells by facilitating Nox2 NADPH oxidase complex formation.
Liang GZ; Cheng LM; Chen XF; Li YJ; Li XL; Guan YY; Du YH
Acta Pharmacol Sin; 2018 Nov; 39(11):1725-1734. PubMed ID: 29977005
[TBL] [Abstract][Full Text] [Related]
11. Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition.
Murdoch CE; Chaubey S; Zeng L; Yu B; Ivetic A; Walker SJ; Vanhoutte D; Heymans S; Grieve DJ; Cave AC; Brewer AC; Zhang M; Shah AM
J Am Coll Cardiol; 2014 Jun; 63(24):2734-41. PubMed ID: 24681145
[TBL] [Abstract][Full Text] [Related]
12. Cyclophilin A is required for angiotensin II-induced p47phox translocation to caveolae in vascular smooth muscle cells.
Soe NN; Sowden M; Baskaran P; Smolock EM; Kim Y; Nigro P; Berk BC
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2147-53. PubMed ID: 23846495
[TBL] [Abstract][Full Text] [Related]
13. Critical role of X-box binding protein 1 in NADPH oxidase 4-triggered cardiac hypertrophy is mediated by receptor interacting protein kinase 1.
Chen L; Zhao M; Li J; Wang Y; Bao Q; Wu S; Deng X; Tang X; Wu W; Liu X
Cell Cycle; 2017 Feb; 16(4):348-359. PubMed ID: 27929749
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway.
Li L; Zhang ZG; Lei H; Wang C; Wu LP; Wang JY; Fu FY; Zhu WG; Wu LL
PLoS One; 2013; 8(1):e49915. PubMed ID: 23349663
[TBL] [Abstract][Full Text] [Related]
15. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
Custodis F; Eberl M; Kilter H; Böhm M; Laufs U
Cardiovasc Res; 2006 Jul; 71(2):342-51. PubMed ID: 16698001
[TBL] [Abstract][Full Text] [Related]
16. Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species.
Liu J; Zhou J; An W; Lin Y; Yang Y; Zang W
Can J Physiol Pharmacol; 2010 Jul; 88(7):745-52. PubMed ID: 20651822
[TBL] [Abstract][Full Text] [Related]
17. NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways.
Zhao QD; Viswanadhapalli S; Williams P; Shi Q; Tan C; Yi X; Bhandari B; Abboud HE
Circulation; 2015 Feb; 131(7):643-55. PubMed ID: 25589557
[TBL] [Abstract][Full Text] [Related]
18. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Zhang Q; Tan Y; Zhang N; Yao F
Exp Biol Med (Maywood); 2015 Oct; 240(10):1352-61. PubMed ID: 25488910
[TBL] [Abstract][Full Text] [Related]
19. Endothelial NADPH oxidase 4 protects against angiotensin II-induced cardiac fibrosis and inflammation.
Wang M; Murdoch CE; Brewer AC; Ivetic A; Evans P; Shah AM; Zhang M
ESC Heart Fail; 2021 Apr; 8(2):1427-1437. PubMed ID: 33511759
[TBL] [Abstract][Full Text] [Related]
20. LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction.
Chen X; Zhang F; Hu G; Li X; Wang L; Li C; Huo C; Xu R; Hou L; Wang N; Wang X
Theranostics; 2022; 12(13):5824-5835. PubMed ID: 35966575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
